Therefore, the sustained TβRI expression potentially mediated by PARP inhibition on intra-tumor T cells can contribute to increase the differentiation rate toward a CD103+ phenotype, distinctive of Tres, thus indirectly promoting higher intra-tumor T cell infiltration and better anti-tumor effector function. The gene discussed is ITGAE; the disease is neoplasm.